New registry tool aims to stop heart patients from falling through the cracks

NCT ID NCT07606131

First seen Jun 25, 2026 · Last updated Jul 14, 2026 · Updated 3 times

Summary

This study tests a cloud-based tool called ACT+ to help people in Uganda get follow-up care after a positive screening for rheumatic heart disease. Researchers will work with local providers to improve the tool and then see if it increases the number of people who complete a confirmatory heart ultrasound. The study involves 16 participants and focuses on understanding barriers and improving the care process.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ACT+ strategy (a cloud-based case management tool)
What this could lead to
If successful, this could point toward a practical way to ensure more people get the follow-up care they need after a heart disease screening.
What could go wrong
This is a very small, early-stage study (16 participants) focused on process improvement, not a treatment. It may not work in other settings or lead to direct health benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RHEUMATIC HEART DISEASE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Uganda Heart Institute

    Kampala, Uganda

More trials for these conditions

Other studies related to the condition(s) this trial covers.